Arch Therapeutics Inc (ARTH)

[formerdtrader]

People are overreacting. It is not necessarily bad news.. in fact it could be very good news. When companies ask the SEC for special treatment about keeping information private, it is typically related to pricing contracts that, if leaked to the public, could undermine their business by affecting how competitors could potentially undercut their pricing. Especially in pre-approved medical devices and drugs prior to getting full FDA approval.